Patents Assigned to The Institutes for Pharmaceutical Discovery LLC
  • Publication number: 20030018053
    Abstract: Disclosed are substituted indolealkanoic acids useful in the treatment of chronic complications arising from diabetes mellitus. Also disclosed are pharmaceutical compositions containing the compounds and methods of treatment employing the compounds, as well as methods for their synthesis.
    Type: Application
    Filed: June 28, 2002
    Publication date: January 23, 2003
    Applicant: The Institute for Pharmaceutical Discovery LLC.
    Inventors: Michael Jones, David Gunn, John Jones, Michael Van Zandt
  • Patent number: 6426344
    Abstract: Disclosed are substituted indolealkanoic acids useful in the treatment of chronic complications arising from diabetes mellitus. Also disclosed are pharmaceutical compositions containing the compounds and methods of treatment employing the compounds, as well as methods for their synthesis.
    Type: Grant
    Filed: March 27, 2001
    Date of Patent: July 30, 2002
    Assignee: The Institutes for Pharmaceutical Discovery LLC
    Inventors: Michael Lee Jones, David Gunn, John Howard Jones, Michael C. Van Zandt
  • Patent number: 6420426
    Abstract: Disclosed are substituted phenoxyacetic acids useful in the treatment of chronic complications arising from diabetes mellitus. Also disclosed are pharmaceutical compositions containing the compounds, alone or in combination with other therapeutic agents, and methods of treatment employing the compounds and pharmaceutical compositions, as well as methods for their synthesis.
    Type: Grant
    Filed: June 23, 2000
    Date of Patent: July 16, 2002
    Assignee: The Institute for Pharmaceutical Discovery LLC
    Inventor: Michael C. Van Zandt